LP-300 Clinical Trials

1 actively recruiting trial across 1 location

No change since May 2026

Also known as: BNP7787, Dimesna, Tavocept

Pipeline

Phase 2: 1

Top Sponsors

Lantern Pharma Inc.1

Indications

Adenocarcinoma of Lung1
Carcinoma, Non-Small-Cell Lung1
Lung Cancer1
Cancer1

Beverly Hills, California1 trial

A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma

Precision NextGen Oncology and Research Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.